These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7117382)

  • 1. Different effects of behaviorally equipotent doses of amphetamine and methamphetamine on brain biogenic amines: specific increase of phenylethylamine by amphetamine.
    Chuang LW; Karoum F; Wyatt RJ
    Eur J Pharmacol; 1982 Jul; 81(3):385-92. PubMed ID: 7117382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the administration of amphetamine, either alone or in combination with reserpine or cocaine, on regional brain beta-phenylethylamine and dopamine release.
    Karoum F; Wolf ME; Mosnaim AD
    Am J Ther; 1997; 4(9-10):333-42. PubMed ID: 10423628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.
    Shoblock JR; Sullivan EB; Maisonneuve IM; Glick SD
    Psychopharmacology (Berl); 2003 Feb; 165(4):359-69. PubMed ID: 12491026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats.
    Paulson PE; Camp DM; Robinson TE
    Psychopharmacology (Berl); 1991; 103(4):480-92. PubMed ID: 2062986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of biogenic amines and behaviour.
    Magyar K
    Act Nerv Super (Praha); 1972 Nov; 14(4):303-4. PubMed ID: 5083840
    [No Abstract]   [Full Text] [Related]  

  • 7. Tolerance to the neurotoxic effect of methamphetamine in rats behaviorally sensitized to methamphetamine or amphetamine.
    Abekawa T; Ohmori T; Koyama T
    Brain Res; 1997 Aug; 767(1):34-44. PubMed ID: 9365013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of amphetamine- and methamphetamine-induced locomotor activity in rats: evidence for qualitative differences in behavior.
    Hall DA; Stanis JJ; Marquez Avila H; Gulley JM
    Psychopharmacology (Berl); 2008 Jan; 195(4):469-78. PubMed ID: 17874316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behaviorally equivalent stressors differentially modify the monoamine altering property of d-amphetamine.
    Klauenberg BJ; Kleven MS; Sparber SB
    Pharmacol Biochem Behav; 1985 Sep; 23(3):417-23. PubMed ID: 2413488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trace amine-associated receptor 1 displays species-dependent stereoselectivity for isomers of methamphetamine, amphetamine, and para-hydroxyamphetamine.
    Reese EA; Bunzow JR; Arttamangkul S; Sonders MS; Grandy DK
    J Pharmacol Exp Ther; 2007 Apr; 321(1):178-86. PubMed ID: 17218486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of beta-phenylethylamine and d-amphetamine on rat isolated atria.
    Pesce G; Adler-Graschinsky E
    J Pharmacol Exp Ther; 1983 Oct; 227(1):205-14. PubMed ID: 6555238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral changes and brain energy metabolism dysfunction in rats treated with methamphetamine or dextroamphetamine.
    Feier G; Valvassori SS; Lopes-Borges J; Varela RB; Bavaresco DV; Scaini G; Morais MO; Andersen ML; Streck EL; Quevedo J
    Neurosci Lett; 2012 Nov; 530(1):75-9. PubMed ID: 23022501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration.
    Mao L; Wang JQ
    Synapse; 2001 Sep; 41(3):230-40. PubMed ID: 11418936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the acute effect of amphetamine on the urinary excretion of biogenic amines and metabolites in monkeys.
    Chuang LW; Karoum F; Perlow MJ
    Br J Pharmacol; 1981 Nov; 74(3):571-7. PubMed ID: 7296162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine potentiates the effects of β-phenylethylamine through activation of an amine-gated chloride channel.
    Safratowich BD; Hossain M; Bianchi L; Carvelli L
    J Neurosci; 2014 Mar; 34(13):4686-91. PubMed ID: 24672014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some neurochemical effects of amphetamine, methylamphetamine and p-bromomethylamphetamine in the rat.
    Leonard BE; Shallice SA
    Br J Pharmacol; 1971 Feb; 41(2):198-212. PubMed ID: 5572273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine analogues and brain amines.
    Morgan D; Löfstrandh S; Costa E
    Life Sci I; 1972 Jan; 11(2):83-96. PubMed ID: 4653194
    [No Abstract]   [Full Text] [Related]  

  • 19. A dopaminergic mechanism is involved in the 'anxiogenic-like' response induced by chronic amphetamine treatment: a behavioral and neurochemical study.
    Cancela LM; Basso AM; Martijena ID; Capriles NR; Molina VA
    Brain Res; 2001 Aug; 909(1-2):179-86. PubMed ID: 11478934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of four amphetamines on brain biogenic amines and their metabolites.
    Leonard BE
    Biochem Pharmacol; 1972 May; 21(9):1289-97. PubMed ID: 5038674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.